Assessing the proarrhythmic potential of drugs: Current status of models and surrogate parameters of torsades de pointes arrhythmias

This publication has 250 references indexed in Scilit:

• Long‐term bradycardia caused by atrioventricular block can remodel the canine heart to detect the histamine H₁ blocker terfenadine‐induced torsades de pointes arrhythmias
  British Journal of Pharmacology, 2006
• Sex Modulates the Arrhythmogenic Substrate in Prepubertal Rabbit Hearts with Long QT 2
  Journal of Cardiovascular Electrophysiology, 2005
• Transmural dispersion of repolarization as a key factor of arrhythmogenicity in a novel intact heart model of LQT3
  Cardiovascular Research, 2005
• Temporal repolarization lability differences among genotyped patients with the long QT syndrome
  The American Journal of Cardiology, 2004
• Assessing predictors of drug-induced torsade de pointes
  Trends in Pharmacological Sciences, 2003
• Proarrhythmic potential of halofantrine, terfenadine and clofilium in a modified in vivo model of torsade de pointes
  British Journal of Pharmacology, 2002
• Spectrum of drugs prolonging QT interval and the incidence of torsades de pointes
  European Heart Journal Supplements, 2001
• Mortality in the Survival With ORal D-Sotalol (SWORD) Trial: Why Did Patients Die? 11This work was supported by a grant from Bristol-Myers Squibb, Princeton, New Jersey.
  The American Journal of Cardiology, 1998
• Inherited ventricular arrhythmias and sudden death in German shepherd dogs
  Journal of the American College of Cardiology, 1994
• Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs
  JAMA, 1993